Sun Simiao Pharmaceutical

Hunan Sun Simiao Pharmaceutical Co., Ltd.


Hunan Sun Simiao Pharmaceutical Co., Ltd. inherits the medical ethics values of "Great Medical Sincerity" from Sun Simiao, the "King of Medicine". While carrying forward traditional Chinese medicine (TCM) culture, we always adhere to an innovative development strategy featuring technological leadership and market orientation. We're building a large biomedical industry pattern where modern Chinese medicine, biopharmaceuticals, and big health products develop in a coordinated way.


Relying on the strong research strengths of  The Chinese University of Hong Kong, Shenzhen, Institute for New Medicine (which ranks first in Asia in QS medical rankings), we closely cooperate with them in TCM research projects. This promotes the integration of traditional and modern medicine, improves disease diagnosis process and treatment effects, and explores new drug Research & Discovery and achievement transformation.


At present, Hunan Sun Simiao Advanced Pharmaceuticals also holds stakes in hundreds of pharmaceutical chain stores in Henan and other regions, two GMP-certified pharmaceutical factories, and supporting smart pharmaceutical warehouses, focusing on the production of Chinese herbal pieces and health products.


Hunan Sun Simiao Pharmaceutical Co., Ltd. focuses on modern Chinese medicine, synthetic biology, classical formula protection and other fields. We have established a "four-in-one" R&D model of independent R&D, cooperative R&D, product introduction, and investment in market license priority. This drives the modern transformation of TCM to meet national strategies, social needs, people's visions, and contemporary technological development. We are committed to building a high-tech leading enterprise in China's modern TCM industry.